tiprankstipranks
Advertisement
Advertisement

AURA Stock Latest News

Aura Biosciences Reaffirmed at Buy with Unchanged $23 Target on Bel-sar’s Vision-Sparing Potential
RatingsAura Biosciences Reaffirmed at Buy with Unchanged $23 Target on Bel-sar’s Vision-Sparing Potential
3d ago
AURA
Aura Biosciences strengthens board with new independent director
PremiumCompany Announcements
Aura Biosciences strengthens board with new independent director
18d ago
8K
AURA
3 Under-$10 Stocks With Strong Upside to Watch in July 2026, According to Analysts
PremiumMarket News
3 Under-$10 Stocks With Strong Upside to Watch in July 2026, According to Analysts
23d ago
VFS
AURA
Aura Biosciences Announces Results of 2026 Annual Meeting
PremiumCompany Announcements
Aura Biosciences Announces Results of 2026 Annual Meeting
1M ago
8K
AURA
Aura Biosciences completes enrollment in belzupacap sarotalocan trial
PremiumThe Fly
Aura Biosciences completes enrollment in belzupacap sarotalocan trial
2M ago
AURA
Aura Biosciences price target lowered to $17 from $26 at Leerink
PremiumThe FlyAura Biosciences price target lowered to $17 from $26 at Leerink
2M ago
AURA
Aura Biosciences reports Q1 results, appoints new CEO
Premium
Company Announcements
Aura Biosciences reports Q1 results, appoints new CEO
3M ago
8K
AURA
Aura Biosciences Completes Major Underwritten Equity Financing
Premium
Company Announcements
Aura Biosciences Completes Major Underwritten Equity Financing
3M ago
8K
AURA
Aura Biosciences Announces Stock Repurchase Agreement with Shareholder
PremiumCompany Announcements
Aura Biosciences Announces Stock Repurchase Agreement with Shareholder
3M ago
8K
AURA
Aura Biosciences $260M Spot Secondary priced at $6.00
PremiumThe Fly
Aura Biosciences $260M Spot Secondary priced at $6.00
3M ago
AURA
Aura Biosciences Advances CoMpass Phase 3 Trial Progress
PremiumCompany Announcements
Aura Biosciences Advances CoMpass Phase 3 Trial Progress
3M ago
8K
AURA
Aura Biosciences announces common stock, pre-funded warrant offering
PremiumThe Fly
Aura Biosciences announces common stock, pre-funded warrant offering
3M ago
AURA
Aura Biosciences says Natalie Holles to succeed Elisabet de los Pinos as CEO
PremiumThe FlyAura Biosciences says Natalie Holles to succeed Elisabet de los Pinos as CEO
3M ago
AURA
Aura Biosciences price target raised to $15 from $13 at Evercore ISI
Premium
The Fly
Aura Biosciences price target raised to $15 from $13 at Evercore ISI
3M ago
AURA
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
Premium
Ratings
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
4M ago
AURA
Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
PremiumCompany Announcements
Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
4M ago
8K
AURA
Is AURA a Buy, Before Earnings?
PremiumPre-Earnings
Is AURA a Buy, Before Earnings?
4M ago
AURA
Aura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer
PremiumCompany Announcements
Aura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer
5M ago
AURA
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences
PremiumRatings
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences
8M ago
AURA
Aura Biosciences re-initiated with an Outperform at Evercore ISI
PremiumThe FlyAura Biosciences re-initiated with an Outperform at Evercore ISI
8M ago
AURA
Buy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
Premium
Ratings
Buy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
8M ago
AURA
Aura Biosciences Reports Q3 2025 Financial Results
Premium
Company Announcements
Aura Biosciences Reports Q3 2025 Financial Results
8M ago
AURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >